Back
ESC Premium Access

Incidence rates of oedema with triple therapy amlodipine/valsartan/HCTZ as compared to valsartan/amlodipine and valsartan/HCTZ dual combination therapy

Session: Poster Session 2 - Hypertension treatment old and new
Topic: Pharmacotherapy
Speaker: Professor R. Duesing (Bonn, DE)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Professor Rainer Duesing

Hypertoniezentrum Bonn, Bonn (Germany)
0 follower

9 more presentations in this session

Rates of adherence to modern antihypertensive drugs in resistant hypertension

Speaker: Doctor E. Kocianova (Olomouc, CZ)

Access
Abstract
Slides
Like
Thumbnail

Non-steroid anti-inflammatory drug consumption decrease antihypertensive treatment efficacy in postenopausal women

Speaker: Professor N. Izmozherova (Yekaterinburg, RU)

Access
Abstract
Like
Thumbnail

Plasma levels of ST2 - predictive factor of unfavourable outcome in hypertensive patients

Speaker: Doctor A. Farcas (Cluj Napoca, RO)

Access
Abstract
Like
Thumbnail

Long-term treatment with LCZ696 (sacubitril/valsartan) improves cardiac and renal function in stroke-prone spontaneously hypertensive rats

Speaker: Professor Y. Takeda (Uchinada, JP)

Access
Abstract
Slides
Like
Thumbnail

Effect of perindopril/indapamide/amlodipine fixed-dose combination on peripheral and central hemodynamics and vascular wall stiffness parameters in patients with uncontrolled hypertension

Speaker: Doctor T. Netchessova (Minsk, BY)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 2 - Hypertension treatment old and new

Speakers: Professor R. Duesing, Doctor E. Kocianova, Professor N. Izmozherova, Doctor A. Farcas, Professor Y. Takeda...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources